메뉴 건너뛰기




Volumn 32, Issue 1, 1999, Pages 155-158

Dexrazoxane (ICRF-187)

Author keywords

Anthracyclines; Cardiotoxicity; Iron homeostasis; Topoisomerase II

Indexed keywords

1,2 PROPANEDIAMINE N,N' DIACETAMIDE N,N' DIACETIC ACID; ANTHRACYCLINE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; FREE RADICAL; IRON COMPLEX; RAZOXANE;

EID: 0032890136     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00100-1     Document Type: Review
Times cited : (44)

References (31)
  • 1
    • 0027343763 scopus 로고
    • Strategies for prevention of anthracycline cardiotoxicity
    • Basser R.L., Green M.D. Strategies for prevention of anthracycline cardiotoxicity. Cancer Treat. Rev. 19:1993;55-77.
    • (1993) Cancer Treat. Rev. , vol.19 , pp. 55-77
    • Basser, R.L.1    Green, M.D.2
  • 2
    • 0027169157 scopus 로고
    • Cardioprotection by ICRF-187 against high dose anthracycline toxicity in children with malignant disease
    • Bu'Lock F.A., Gabriel H.M., Oakhill A., Mott M.G., Martin R.P. Cardioprotection by ICRF-187 against high dose anthracycline toxicity in children with malignant disease. Br. Heart J. 70:1993;185-188.
    • (1993) Br. Heart J. , vol.70 , pp. 185-188
    • Bu'Lock, F.A.1    Gabriel, H.M.2    Oakhill, A.3    Mott, M.G.4    Martin, R.P.5
  • 3
    • 0028959660 scopus 로고
    • Ferrous ion strongly promotes the ring opening of the hydrolysis intermediates of the antioxidant cardioprotective agent dexrazoxane (ICRF-187)
    • Buss J.L., Hasinoff B.B. Ferrous ion strongly promotes the ring opening of the hydrolysis intermediates of the antioxidant cardioprotective agent dexrazoxane (ICRF-187). Arch. Biochem. Biophys. 317:1995;121-127.
    • (1995) Arch. Biochem. Biophys. , vol.317 , pp. 121-127
    • Buss, J.L.1    Hasinoff, B.B.2
  • 4
    • 0018915753 scopus 로고
    • Enzymatic defenses of the mouse heart against reactive oxygen species
    • Doroshow J.H., Locker G.Y., Myers C.E. Enzymatic defenses of the mouse heart against reactive oxygen species. J. Clin. Invest. 65:1980;128-135.
    • (1980) J. Clin. Invest. , vol.65 , pp. 128-135
    • Doroshow, J.H.1    Locker, G.Y.2    Myers, C.E.3
  • 5
    • 0028329736 scopus 로고
    • Cell cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 and ICRF-159
    • Gorbsky G.J. Cell cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 and ICRF-159. Cancer Res. 54:1994;1042-1048.
    • (1994) Cancer Res. , vol.54 , pp. 1042-1048
    • Gorbsky, G.J.1
  • 7
    • 0024573486 scopus 로고
    • The interaction of the cardioprotective agent ICRF-187 (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane; Its hydrolysis product (ICRF-198), and other chelating agents with the Fe (III) and Cu (II) complexes of adriamycin
    • Hasinoff B.B. The interaction of the cardioprotective agent ICRF-187 (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane; its hydrolysis product (ICRF-198), and other chelating agents with the Fe (III) and Cu (II) complexes of adriamycin. Agents Action Suppl. 26:1989;378-385.
    • (1989) Agents Action Suppl , vol.26 , pp. 378-385
    • Hasinoff, B.B.1
  • 8
    • 0027517827 scopus 로고
    • The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotecitve agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl-propane] and its hydrolysis product ADR-925
    • Hasinoff B.B., Kala S.V. The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotecitve agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl-propane] and its hydrolysis product ADR-925. Agents Actions Suppl. 39:1993;72-81.
    • (1993) Agents Actions Suppl , vol.39 , pp. 72-81
    • Hasinoff, B.B.1    Kala, S.V.2
  • 9
    • 0028217545 scopus 로고
    • An HPLC and spectrometric study of the hydrolysis of ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane) and its open-ring hydrolysis intermediates
    • Hasinoff B.B. An HPLC and spectrometric study of the hydrolysis of ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane) and its open-ring hydrolysis intermediates. Int. J. Pharmacol. 107:1994;67-76.
    • (1994) Int. J. Pharmacol. , vol.107 , pp. 67-76
    • Hasinoff, B.B.1
  • 10
    • 0026636441 scopus 로고
    • Free radicals, antioxidants and human disease. Where are we now
    • Halliwell B., Gutteridge J.M.C., Cross C.E. Free radicals, antioxidants and human disease. Where are we now. J. Lab. Clin. Med. 119:1992;598-620.
    • (1992) J. Lab. Clin. Med. , vol.119 , pp. 598-620
    • Halliwell, B.1    Gutteridge, J.M.C.2    Cross, C.E.3
  • 11
    • 0029758487 scopus 로고    scopus 로고
    • Molecular control of vertebrate iron metabolism: MRNA based regulatory circuits operated by iron, nitric oxide and oxidative stress
    • Hentze M.W., Kühn L.C. Molecular control of vertebrate iron metabolism. mRNA based regulatory circuits operated by iron, nitric oxide and oxidative stress Proc Natl Acad Sci USA. 93:1996;8175-8182.
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 8175-8182
    • Hentze, M.W.1    Kühn, L.C.2
  • 12
    • 0019518585 scopus 로고
    • Reduction of chronic doxirubicin cardiotoxicity in dogs by pretreatment with (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187)
    • Herman E.H., Ferrans V.J. Reduction of chronic doxirubicin cardiotoxicity in dogs by pretreatment with (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187). Cancer Res. 41:1981;3436-3440.
    • (1981) Cancer Res. , vol.41 , pp. 3436-3440
    • Herman, E.H.1    Ferrans, V.J.2
  • 13
    • 0028080144 scopus 로고
    • Comparison of the protective effects of desferrioxamine and ICRF-187 against doxorubicin-induced toxicity in spontaneously hypertensive rats
    • Herman E.H., Zhang J., Ferrans V.J. Comparison of the protective effects of desferrioxamine and ICRF-187 against doxorubicin-induced toxicity in spontaneously hypertensive rats. Cancer Chemother. Pharamcol. 35:1994;93-100.
    • (1994) Cancer Chemother. Pharamcol. , vol.35 , pp. 93-100
    • Herman, E.H.1    Zhang, J.2    Ferrans, V.J.3
  • 14
    • 0027661677 scopus 로고
    • Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine. Studies in rat heart cells in culture
    • Hershko C., Link G., Tzahor A., Kaltwasser J.P., Athias P., Grynberg A., Pinson A. Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine. Studies in rat heart cells in culture. J. Lab. Clin. Med. 122:1993;245-251.
    • (1993) J. Lab. Clin. Med. , vol.122 , pp. 245-251
    • Hershko, C.1    Link, G.2    Tzahor, A.3    Kaltwasser, J.P.4    Athias, P.5    Grynberg, A.6    Pinson, A.7
  • 15
    • 0029891617 scopus 로고    scopus 로고
    • ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumours
    • Holm B., Jensen P.B., Sehested M. ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumours. Cancer Chemother. Pharmacol. 38:1996;203-209.
    • (1996) Cancer Chemother. Pharmacol. , vol.38 , pp. 203-209
    • Holm, B.1    Jensen, P.B.2    Sehested, M.3
  • 16
  • 17
    • 0021259518 scopus 로고
    • Deferoxamine: A reversible S-phase inhibitor of human lymphocyte proliferation
    • Lederman H.M., Cohen A., Lee J.W.J., Freedman M., Gelfand E.W. Deferoxamine. a reversible S-phase inhibitor of human lymphocyte proliferation Blood. 64:1984;748-753.
    • (1984) Blood , vol.64 , pp. 748-753
    • Lederman, H.M.1    Cohen, A.2    Lee, J.W.J.3    Freedman, M.4    Gelfand, E.W.5
  • 18
    • 0029892535 scopus 로고    scopus 로고
    • Inhibition of anthracycline semiquinone formation by ICRF-187 (dexrazoxane) in cells
    • Malisza K.L., Hasinoff B.B. Inhibition of anthracycline semiquinone formation by ICRF-187 (dexrazoxane) in cells. Free Radic. Biol. Med. 20:1996;905-914.
    • (1996) Free Radic. Biol. Med. , vol.20 , pp. 905-914
    • Malisza, K.L.1    Hasinoff, B.B.2
  • 19
    • 0027502154 scopus 로고
    • Iron sequestration by macrophages decreases the potential of extracellular hydroxyl radical formation
    • Olakanmi O., McGowan S.E., Hayek M.B., Britigan B.E. Iron sequestration by macrophages decreases the potential of extracellular hydroxyl radical formation. J Clin. Invest. 91:1993;889-899.
    • (1993) J Clin. Invest. , vol.91 , pp. 889-899
    • Olakanmi, O.1    McGowan, S.E.2    Hayek, M.B.3    Britigan, B.E.4
  • 20
    • 0030007125 scopus 로고    scopus 로고
    • Mapping of DNA topoisomerase II poisons (etoposide) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase catalytic cycle
    • Sehested M., Jensen P.B. Mapping of DNA topoisomerase II poisons (etoposide) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase catalytic cycle. Biochem. Pharmacol. 51:1996;879-886.
    • (1996) Biochem. Pharmacol. , vol.51 , pp. 879-886
    • Sehested, M.1    Jensen, P.B.2
  • 21
    • 0014938009 scopus 로고
    • Mode of action of the cytostatic agent "iCRF-159"
    • Sharpe H.B.A., Field E.O., Hellmann K. Mode of action of the cytostatic agent "ICRF-159" Nature. 226:1970;524-526.
    • (1970) Nature , vol.226 , pp. 524-526
    • Sharpe, H.B.A.1    Field, E.O.2    Hellmann, K.3
  • 25
    • 0026763513 scopus 로고
    • In vitro effects of three iron chelators on mitogen activated lymphocytes: Identification of differences in their mechanism of action
    • Van Reyk D.M., Sarel S., Hunt N.H. In vitro effects of three iron chelators on mitogen activated lymphocytes. Identification of differences in their mechanism of action Int. J. Immunopharmacol. 14:1992;925-932.
    • (1992) Int. J. Immunopharmacol. , vol.14 , pp. 925-932
    • Van Reyk, D.M.1    Sarel, S.2    Hunt, N.H.3
  • 27
    • 0030790471 scopus 로고    scopus 로고
    • Modulation of transferrin receptor expression by dexrazoxane (ICRF-187) via activation of iron regulatory protein
    • Weiss G., Kastner S., Brock J., Thaler J., Grunewald K. Modulation of transferrin receptor expression by dexrazoxane (ICRF-187) via activation of iron regulatory protein. Biochem. Pharmacol. 53:1997;1419-1424.
    • (1997) Biochem. Pharmacol. , vol.53 , pp. 1419-1424
    • Weiss, G.1    Kastner, S.2    Brock, J.3    Thaler, J.4    Grunewald, K.5
  • 28
    • 0029051815 scopus 로고
    • Linkage of cellular immunity to iron metabolism
    • Weiss G., Wachter H., Fuchs D. Linkage of cellular immunity to iron metabolism. Immunol. Today. 16:1995;495-500.
    • (1995) Immunol. Today , vol.16 , pp. 495-500
    • Weiss, G.1    Wachter, H.2    Fuchs, D.3
  • 30
    • 0026147704 scopus 로고
    • Proliferation and cell cycle dependent differences in the expresion of the 170 kD and 180 kD forms of topoisomerase II in NIH-3T3 cells
    • Woessner R.D., Mattern M.R., Mirabelli C.K., Johnson R.K., Drake F.H. Proliferation and cell cycle dependent differences in the expresion of the 170 kD and 180 kD forms of topoisomerase II in NIH-3T3 cells. Cell Growth Diff. 2:1991;209-214.
    • (1991) Cell Growth Diff. , vol.2 , pp. 209-214
    • Woessner, R.D.1    Mattern, M.R.2    Mirabelli, C.K.3    Johnson, R.K.4    Drake, F.H.5
  • 31
    • 0022849760 scopus 로고
    • 2 reduction by iron complexes of adriamycin and daunorubicin: The importance of sidechain hydroxyl group
    • 2 reduction by iron complexes of adriamycin and daunorubicin. the importance of sidechain hydroxyl group Biochem. Biophys. Acta. 884:1986;326-336.
    • (1986) Biochem. Biophys. Acta. , vol.884 , pp. 326-336
    • Zweier, J.L.1    Gianni, L.2    Muindi, J.3    Myers, C.E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.